Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mayers

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Characterization of HIV isolates arising after prolonged zidovudine therapyD L Mayers, F E McCutchan, E E Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral ResearchL I Gardner, S H Harrison, C W Hendrix, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure RegimensKatherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
The New England Journal of Medicine|August 29, 2003
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virusJody Lawrence, Douglas L Mayers, Katherine Huppler Hullsiek, et al.
Blood|July 1, 1996
Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitroS Kaushal, V F La Russa, S Gartner, et al.
The Lancet. Infectious Diseases|November 21, 2017
Ebola virus disease: an update on post-exposure prophylaxisWilliam A Fischer, Pauline Vetter, Daniel G Bausch, et al.
AIDS (London, England)|July 14, 2000
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.
Science (New York, N.Y.)|June 28, 1996
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulationB L Levine, J D Mosca, J L Riley, et al.
Journal of Clinical Microbiology|July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working GroupR W Shafer, M A Winters, D L Mayers, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Characterization of HIV isolates arising after prolonged zidovudine therapyD L Mayers, F E McCutchan, E E Sanders-Buell, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral ResearchL I Gardner, S H Harrison, C W Hendrix, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure RegimensKatherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
The New England Journal of Medicine|August 29, 2003
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virusJody Lawrence, Douglas L Mayers, Katherine Huppler Hullsiek, et al.
Blood|July 1, 1996
Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitroS Kaushal, V F La Russa, S Gartner, et al.
The Lancet. Infectious Diseases|November 21, 2017
Ebola virus disease: an update on post-exposure prophylaxisWilliam A Fischer, Pauline Vetter, Daniel G Bausch, et al.
AIDS (London, England)|July 14, 2000
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.
Science (New York, N.Y.)|June 28, 1996
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulationB L Levine, J D Mosca, J L Riley, et al.
Journal of Clinical Microbiology|July 1, 1996
Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working GroupR W Shafer, M A Winters, D L Mayers, et al.
Pageof 10